Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancer.
about
GnRH-(1-5) transactivates EGFR in Ishikawa human endometrial cells via an orphan G protein-coupled receptorLuteinizing hormone-releasing hormone receptor targeted agents for prostate cancer.Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry.Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone AnalogsOn the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.
P2860
Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Evaluation of a stable gonadot ...... disorders and prostate cancer.
@en
Evaluation of a stable gonadot ...... disorders and prostate cancer.
@nl
type
label
Evaluation of a stable gonadot ...... disorders and prostate cancer.
@en
Evaluation of a stable gonadot ...... disorders and prostate cancer.
@nl
prefLabel
Evaluation of a stable gonadot ...... disorders and prostate cancer.
@en
Evaluation of a stable gonadot ...... disorders and prostate cancer.
@nl
P2093
P50
P356
P1476
Evaluation of a stable gonadot ...... disorders and prostate cancer.
@en
P2093
Constantin Tamvakopoulos
Evangelos Balafas
George Liapakis
John Matsoukas
Konstantinos Gkountelias
Nikolaos Kostomitsopoulos
Theodore Tselios
P304
P356
10.1124/JPET.110.174375
P407
P577
2010-11-24T00:00:00Z